Cleared Traditional

Liver Incytes, Model 1005 (K201597) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
49d
Days
Class 2
Risk

K201597 is an FDA 510(k) clearance for the Liver Incytes, Model 1005. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Sonic Incytes (Vancouver, CA). The FDA issued a Cleared decision on July 31, 2020 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sonic Incytes devices

Submission Details

510(k) Number K201597 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2020
Decision Date July 31, 2020
Days to Decision 49 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 107d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Z&B Enterprises, Inc.
Rhona Shanker

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 215
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K201597.
IntraSight Mobile
K203719 · Volcano Corporation · Jan 2021
AcuSee AS-P1000 System
K202119 · Weipeng (Suzhou) Medical Devices Co., Ltd. · Oct 2020
CUBEScan BioCon-1100
K201995 · Mcube Technology Co., Ltd. · Aug 2020
FibroScan® 630
K200655 · Echosens · Jul 2020
Auto 3D Bladder Volume Tool
K200980 · Butterfly Network, Inc. · Jun 2020
CUBEScan BioCon-900S
K200749 · Mcube Technology Co., Ltd. · May 2020